Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effectiveness of dupilumab in pediatric patients with a nummular phenotype of atopic dermatitis.

Pediatric dermatology - 1 Jan 2024

Kim Eun Jae, Hlobik Madeline, Ho Tina

Abstract excerpt

The nummular phenotype of atopic dermatitis is clinically characterized by pruritic, coin-shaped plaques that are frequently recalcitrant to treatment. In this study, a retrospective chart review was conducted to evaluate the effectiveness and safety of dupilumab in children with nummular lesions of dermatitis. Twelve out of 14 patients demonstrated significant clinical improvement at a median time of 2.5 months...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antibodies, Monoclonal, Humanized
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Dermatitis, Atopic

Share to Phenotype

Share to Treatment Outcome

Source

Identifiers

PMID: 38303143
DOI: 10.1111/pde.15541

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of dupilumab in pediatric patients with a nummular phenotype of atopic dermatitis.PMID 38303143Read ↗

Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.Semantic proximity Read ↗

Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab.Semantic proximity Read ↗

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 PatientsSemantic proximity Read ↗

Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.Semantic proximity Read ↗

Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin-17A expression: a case report.Semantic proximity Read ↗

Clinical phenotypes of adult atopic dermatitis and related therapies.Semantic proximity Read ↗

Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.Semantic proximity Read ↗

Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.Semantic proximity Read ↗

Optimizing outcomes for paediatric atopic dermatitis.Semantic proximity Read ↗

Clinical response to ustekinumab in CARD14-associated papulosquamous eruption (CAPE) with a new missense mutation in CARD14: a case report and systematic review.Semantic proximity Read ↗

Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.Semantic proximity Read ↗

Excellent response to secukinumab in an infant with severe generalized pustular psoriasis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.